World's Best Scientists 2026 revealed!
Yasuharu Nishimura

Yasuharu Nishimura

D-Index & Metrics

Immunology

D-Index
66
Citations
12855
World Ranking
2794
National Ranking
116

Yasuharu Nishimura publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Yasuharu Nishimura sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 294 publications — 63rd percentile

63% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Yasuharu Nishimura D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Yasuharu Nishimura sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 66 D-Index — 45th percentile

45% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Yasuharu Nishimura is affiliated with Kumamoto University in Japan and focuses their research primarily on medicine, with notable contributions in immunology and microbiology. Their work spans several interconnected subfields including immunology, oncology, dermatology, immunology and allergy, and surgery.

The main topics that Yasuharu Nishimura investigates include:

  • Immunotherapy and Immune Responses
  • CAR-T cell therapy research
  • Immune Cell Function and Interaction
  • Bladder and Urothelial Cancer Treatments
  • Cancer Immunotherapy and Biomarkers
  • Contact Dermatitis and Allergies
  • Asthma and respiratory diseases

Among their recent scientific papers, notable examples are:

  • "A novel coculture system for assessing respiratory sensitizing potential by IL-4 in T cells," 2022, published in ALTEX
  • "Induced pluripotent stem cell-derived myeloid cells expressing OX40 ligand amplify antigen-specific T cells in advanced melanoma," 2020, published in Pigment Cell & Melanoma Research
  • "Contributions of the N-terminal flanking residues of an antigenic peptide from the Japanese cedar pollen allergen Cry j 1 to the T-cell activation by HLA-DP5," 2023, published in International Immunology
  • "Development of HLA-modified induced pluripotent stem cell-derived dendritic cells for a novel cancer immunotherapy," 2022, published in Journal of Oral and Maxillofacial Surgery Medicine and Pathology
  • "PD12-12 TUMOR ANTIGEN VACCINE ENHANCES ANTI-TUMOR EFFECTS OF IMMUNE CHECKPOINT INHIBITORS AGAINST REFRACTORY CANCERS," 2022, published in The Journal of Urology

Yasuharu Nishimura frequently publishes in the following venues:

  • The Journal of Urology (2 publications)
  • ALTEX (1 publication)
  • Pigment Cell & Melanoma Research (1 publication)
  • International Immunology (1 publication)
  • Journal of Oral and Maxillofacial Surgery Medicine and Pathology (1 publication)

Their frequent collaborators include:

  • Atsushi Irie (3 coauthored works)
  • Satoru Senju (2 coauthored works)
  • Shohei Ueda (2 coauthored works)
  • Masatoshi Eto (2 coauthored works)
  • Izuru Mizoguchi (1 coauthored work)

Best Publications

  • Glypican-3, overexpressed specifically in human hepatocellular carcinoma, is a novel tumor marker.

    Tetsuya Nakatsura;Yoshihiro Yoshitake;Satoru Senju;Mikio Monji

  • Ribosome stalling induced by mutation of a CNS-specific tRNA causes neurodegeneration

    Ryuta Ishimura;Gabor Nagy;Ivan Dotu;Huihao Zhou

  • Western versus asian types of multiple sclerosis: Immunogenetically and clinically distinct disorders

    Jun Ichi Kira;Takayuki Kanai;Yasuharu Nishimura;Kenji Yamasaki

  • Combined Blockade of IL6 and PD-1/PD-L1 Signaling Abrogates Mutual Regulation of Their Immunosuppressive Effects in the Tumor Microenvironment.

    Hirotake Tsukamoto;Koji Fujieda;Azusa Miyashita;Satoshi Fukushima

  • Identification of HLA-A2- or HLA-A24-restricted CTL epitopes possibly useful for glypican-3-specific immunotherapy of hepatocellular carcinoma.

    Hiroyuki Komori;Tetsuya Nakatsura;Satoru Senju;Yoshihiro Yoshitake

  • Identification of glypican-3 as a novel tumor marker for melanoma.

    Tetsuya Nakatsura;Toshiro Kageshita;Shosuke Ito;Kazumasa Wakamatsu

  • HLA-DPB1*0501-associated opticospinal multiple sclerosis: clinical, neuroimaging and immunogenetic studies.

    Kenji Yamasaki;Izumi Horiuchi;Motozumi Minohara;Yuji Kawano

  • Generation of dendritic cells and macrophages from human induced pluripotent stem cells aiming at cell therapy

    S Senju;M Haruta;K Matsumura;Y Matsunaga

  • Prevention of experimental autoimmune encephalomyelitis by transfer of embryonic stem cell-derived dendritic cells expressing myelin oligodendrocyte glycoprotein peptide along with TRAIL or programmed death-1 ligand.

    Shinya Hirata;Satoru Senju;Hidetake Matsuyoshi;Daiki Fukuma

  • Association between HLA and Japanese patients with rheumatoid arthritis

    Nobuo Ohta;Yoshi K. Nishimura;Kiyoaki Tanimoto;Yoshihiko Horiuchi

  • Immune-suppressive effects of interleukin-6 on T-cell-mediated anti-tumor immunity.

    Hirotake Tsukamoto;Koji Fujieda;Satoru Senju;Tokunori Ikeda

  • Phase II Clinical Trial of Multiple Peptide Vaccination for Advanced Head and Neck Cancer Patients Revealed Induction of Immune Responses and Improved OS

    Yoshihiro Yoshitake;Daiki Fukuma;Akira Yuno;Masatoshi Hirayama

  • Peptides and drugs containing the same

    Yasuharu Nishimura;Tetsuya Nakatsura;Yusuke Nakamura

  • Allele specificity of structural requirement for peptides bound to HLA-DRB1*0405 and -DRB1*0406 complexes: Implication for the HLA-associated susceptibility to methimazole-induced insulin autoimmune syndrome

    Sho Matsushita;Katsushi Takahashi;Masamichi Motoki;Keiji Komoriya

  • Association of the HLA‐DPB1*0501 allele with anti‐aquaporin‐4 antibody positivity in Japanese patients with idiopathic central nervous system demyelinating disorders

    T. Matsushita;T. Matsuoka;N. Isobe;Y. Kawano

  • Cellular and humoral immune responses to a human pancreatic cancer antigen, coactosin-like protein, originally defined by the SEREX method.

    Tetsuya Nakatsura;Tetsuya Nakatsura;Satoru Senju;Masaaki Ito;Yasuharu Nishimura

  • HLA-A and DPB1 loci confer susceptibility to Grave's disease

    Rui Ping Dong;Akinori Kimura;Ryoko Okubo;Hirotoshi Shinagawa

  • Identification of a novel tumor-associated antigen, cadherin 3/P-cadherin, as a possible target for immunotherapy of pancreatic, gastric, and colorectal cancers

    Katsunori Imai;Shinya Hirata;Atsushi Irie;Satoru Senju

  • Generation and genetic modification of dendritic cells derived from mouse embryonic stem cells

    Satoru Senju;Shinya Hirata;Hidetake Matsuyoshi;Masako Masuda

  • The present status and future prospects of peptide-based cancer vaccines.

    Masatoshi Hirayama;Yasuharu Nishimura

Frequent Co-Authors

Yusuke Nakamura
Yusuke Nakamura National Institutes of Biomedical Innovation, Health and Nutrition
Jun-ichi Kira
Jun-ichi Kira Kyushu University
Hideo Baba
Hideo Baba Kumamoto University
Takehiko Sasazuki
Takehiko Sasazuki Kyushu University
Michio Ogawa
Michio Ogawa Kumamoto University
Hironobu Ihn
Hironobu Ihn Kumamoto University
Akinori Kimura
Akinori Kimura Tokyo Medical and Dental University
Hisao Ogawa
Hisao Ogawa Kumamoto University
Michihiro Yoshimura
Michihiro Yoshimura Jikei University School of Medicine
Hiroshi Hashimoto
Hiroshi Hashimoto Juntendo University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in immunology, exploring related healthcare degrees can open diverse career opportunities. Many students pursue nursing as a complementary pathway since nurses often work closely with immunologists in clinical settings. If you’re new to healthcare, there are several online nursing programs for non nurses designed to help you transition smoothly into nursing roles while balancing other commitments.

Accelerated Bachelor of Science in Nursing (ABSN) programs offer a fast track for those who already hold a non-nursing degree. If admission competitiveness is a concern, it’s helpful to review easiest ABSN programs to get into, which highlight programs with more accessible entry requirements.

Licensed Practical Nurse (LPN) programs provide a quicker route into healthcare with less stringent prerequisites. When searching for options, consider the easy LPN programs to get into to find programs suited to your background and goals.

For advanced practice roles, nurse practitioner degrees offer expanded responsibilities in patient care. Those seeking flexible admissions should explore nurse practitioner programs with easy admission to identify viable pathways without extensive barriers.

Best Scientists Citing Yasuharu Nishimura

Trending Scientists

Recently Published Articles